Abstract
Purpose We developed a method for predicting truenegative lymph node metastases in clinical IA non-small lung cancer (NSCLC) by the combined evaluation of computed tomography (CT), 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) findings and the maximum standardized uptake value (SUVmax) of primary tumors. Methods The subjects of this study were 94 patients with clinical stage IA NSCLC who underwent both preoperative CT and FDG-PET. We analyzed the relationship between the SUVmax of primary tumors and various clinicopathological factors to find the best method available for assessing true-negative lymph node metastasis. Results The pathological stages were IA (n = 80), IB (n = 4), IIA (n = 5), IIIA (n = 4), and IV (n = 1). Pathologic lymph node metastasis was recognized in nine patients and the SUVmax of these tumors ranged from 3.3 to 20.3. A SUVmax of 3.0 was defined as the cut-off point and patients were dichotomized according to this point. Tumors with SUVmax of 3.0 or less were associated with a significantly lower incidence of pleural and vascular invasion and were characterized by the degree of differentiation. Conclusion The SUVmax of primary tumors reflects the grade of malignancy; therefore, the combined evaluation of FDG-PET/CT findings with the SUVmax of primary tumors may help predict lymph node metastasis negativity.
| Original language | English |
|---|---|
| Pages (from-to) | 934-939 |
| Number of pages | 6 |
| Journal | Surgery today |
| Volume | 42 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - Oct 1 2012 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Surgery
Cite this
Prediction of true-negative lymph node metastasis in clinical IA non-small cell lung cancer by measuring standardized uptake values on positron emission tomography. / Takenaka, Tomoyoshi; Yano, Tokujiro; Morodomi, Yosuke; Ito, Kensaku; Miura, Naoko; Kawano, Daigo; Shoji, Fumihiro; Baba, Shingo; Abe, Koichiro; Honda, Hiroshi; Maehara, Yoshihiko.
In: Surgery today, Vol. 42, No. 10, 01.10.2012, p. 934-939.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Prediction of true-negative lymph node metastasis in clinical IA non-small cell lung cancer by measuring standardized uptake values on positron emission tomography
AU - Takenaka, Tomoyoshi
AU - Yano, Tokujiro
AU - Morodomi, Yosuke
AU - Ito, Kensaku
AU - Miura, Naoko
AU - Kawano, Daigo
AU - Shoji, Fumihiro
AU - Baba, Shingo
AU - Abe, Koichiro
AU - Honda, Hiroshi
AU - Maehara, Yoshihiko
PY - 2012/10/1
Y1 - 2012/10/1
N2 - Purpose We developed a method for predicting truenegative lymph node metastases in clinical IA non-small lung cancer (NSCLC) by the combined evaluation of computed tomography (CT), 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) findings and the maximum standardized uptake value (SUVmax) of primary tumors. Methods The subjects of this study were 94 patients with clinical stage IA NSCLC who underwent both preoperative CT and FDG-PET. We analyzed the relationship between the SUVmax of primary tumors and various clinicopathological factors to find the best method available for assessing true-negative lymph node metastasis. Results The pathological stages were IA (n = 80), IB (n = 4), IIA (n = 5), IIIA (n = 4), and IV (n = 1). Pathologic lymph node metastasis was recognized in nine patients and the SUVmax of these tumors ranged from 3.3 to 20.3. A SUVmax of 3.0 was defined as the cut-off point and patients were dichotomized according to this point. Tumors with SUVmax of 3.0 or less were associated with a significantly lower incidence of pleural and vascular invasion and were characterized by the degree of differentiation. Conclusion The SUVmax of primary tumors reflects the grade of malignancy; therefore, the combined evaluation of FDG-PET/CT findings with the SUVmax of primary tumors may help predict lymph node metastasis negativity.
AB - Purpose We developed a method for predicting truenegative lymph node metastases in clinical IA non-small lung cancer (NSCLC) by the combined evaluation of computed tomography (CT), 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) findings and the maximum standardized uptake value (SUVmax) of primary tumors. Methods The subjects of this study were 94 patients with clinical stage IA NSCLC who underwent both preoperative CT and FDG-PET. We analyzed the relationship between the SUVmax of primary tumors and various clinicopathological factors to find the best method available for assessing true-negative lymph node metastasis. Results The pathological stages were IA (n = 80), IB (n = 4), IIA (n = 5), IIIA (n = 4), and IV (n = 1). Pathologic lymph node metastasis was recognized in nine patients and the SUVmax of these tumors ranged from 3.3 to 20.3. A SUVmax of 3.0 was defined as the cut-off point and patients were dichotomized according to this point. Tumors with SUVmax of 3.0 or less were associated with a significantly lower incidence of pleural and vascular invasion and were characterized by the degree of differentiation. Conclusion The SUVmax of primary tumors reflects the grade of malignancy; therefore, the combined evaluation of FDG-PET/CT findings with the SUVmax of primary tumors may help predict lymph node metastasis negativity.
UR - http://www.scopus.com/inward/record.url?scp=84868001133&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84868001133&partnerID=8YFLogxK
U2 - 10.1007/s00595-012-0277-7
DO - 10.1007/s00595-012-0277-7
M3 - Article
C2 - 22864936
AN - SCOPUS:84868001133
VL - 42
SP - 934
EP - 939
JO - Surgery Today
JF - Surgery Today
SN - 0941-1291
IS - 10
ER -